Similarly, CXCL9 expression in plasma was significantly higher in patients with joint involvement, blood involvement, kidney involvement, and ILD, compared to pSS-non-EGM patients, except for those with peripheral nervous system involvement and rash involvement. The gene discussed is CXCL9; the disease is peeling skin syndrome.